ClinicalTrials.Veeva

Menu

Development of Diabetes Mobile Application

N

National University of Malaysia

Status and phase

Unknown
Phase 3

Conditions

Type 2 Diabetes Mellitus

Treatments

Device: Diabetes Mobile Application

Study type

Interventional

Funder types

Other

Identifiers

NCT04686201
Diabetes Apps

Details and patient eligibility

About

this study is to measure the effectiveness of a diabetes mobile application for improving patient's knowledge, compliance and diabetes control among uncontrolled Type 2 Diabetes Mellitus mellitus patients in Kedah

Full description

Specific Objective

  1. To develop and validate a diabetes mobile-app (MyD-App) for patients with uncontrolled Type 2 Diabetes Mellitus.
  2. To measure the effectiveness of a diabetes mobile application for improving knowledge, compliance and control using the newly developed and validated MyD-App among patients with uncontrolled Type 2 Diabetes Mellitus.

Hypothesis

  1. There is an increased in patient's knowledge on diabetes after MyD-App usage.
  2. There is an increased in patient's compliance on medication and treatment after MyD-App usage.
  3. There is a diabetes control improvement (HbA1C < 6.5% or HbA1C reduction ≥ 1%) among Type 2 Diabetes Mellitus patients in Kedah after MyD-App usage.

Enrollment

80 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age 18-80 years old
  • Diagnosed with type 2 diabetes mellitus by a registered medical doctor.
  • Registered and actively follow up in the health clinics at selected districts. (actively follow up: follow up at the clinic for at least once in a year).
  • Own a smartphone with the Android platform.
  • HbA1C >7%

Exclusion criteria

  • GDM
  • Illiterate
  • Anemia / Thalassemia
  • Not agree to be the sample for the study

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

80 participants in 2 patient groups

intervention group
Experimental group
Treatment:
Device: Diabetes Mobile Application
control group
No Intervention group

Trial contacts and locations

1

Loading...

Central trial contact

MOHD NAZRIN JAMHARI, MPH; MOHD ROHAIZAT HASSAN, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems